We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Small Compound Able to Stave Tumor and Stop its Growth

News   Jan 19, 2018 | Original story from Vanderbilt University Medical Center (VUMC)

 
Small Compound Able to Stave Tumor and Stop its Growth

This computationally derived homology model of glutamine transporter shows small molecule inhibitor binding in the transporter’s orange-red transmembrane region. Credit: VUMC

 
 
 

RELATED ARTICLES

Making Custom-designed Natural Products

News

Microorganisms often assemble natural products similar to industrial assembly lines. Certain enzymes, non-ribosomal peptide synthetases (NRPS) play a key role in this process. Biotechnologists have now discovered how these enzymes interact with each other, bringing them one step closer to their goal of engineering peptide natural products.

READ MORE

Drug Could Sustain Oxygen-Starved Hearts

News

In new studies a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia. Unlike its experimental predecessors, the new drug does not appear to cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. Instead, the new drug delivers its precious oxygen cargo only to the tissues that need it most.

READ MORE

Immunotherapy Success for Triple-Negative Breast Cancer

News

New research has shown that by using a combination of immunotherapy and chemotherapy the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE